You have 9 free searches left this month | for more free features.

Iloprost

Showing 26 - 50 of 131

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hypertension, Pulmonary, Cardiac Failure, Pulmonary Vascular Resistance Abnormality Trial in Athens (levosimendan at a dose of 6

Recruiting
  • Hypertension, Pulmonary
  • +2 more
  • levosimendan at a dose of 6 mcg/kg
  • milrinone at a dose of 50 mcg/kg
  • Athens, Greece
    Onassis Cardiac Surgery Center
Feb 8, 2022

Pulmonary Hypertension, Pulmonary Arterial Hypertension Trial in Giessen, Bad Nauheim (Iloprost)

Completed
  • Pulmonary Hypertension
  • Pulmonary Arterial Hypertension
  • Iloprost
  • Giessen, Hesse, Germany
  • +1 more
Oct 25, 2018

Inhaled Treatment With Ventavis in Pulmonary Hypertension

Completed
  • Hypertension, Pulmonary
  • Iloprost (Ventavis, BAYQ6256)
  • Multiple Locations, Russian Federation
    (unnamed)
Mar 25, 2019

BMPR-2 Gene Mutations on Hemodynamic Response by Iloprost

Completed
  • Pulmonary Arterial Hypertension
  • Iloprost
  • Bucheon, Korea, Republic of
  • +5 more
Dec 25, 2018

Diabetes, Arteriosclerosis, Peripheral Arterial Occlusive Disease Trial in Vienna (Ilomedin)

Unknown status
  • Diabetes
  • +3 more
  • Vienna, Austria
    Department of vascular and endovascular surgery, Georg Hagmüller
Oct 16, 2018

Chronic Thrombo-embolic Pulmonary Hypertension: Classification

Completed
  • Chronic Thromboembolic Pulmonary Hypertension
  • Idiopathic Pulmonary Arterial Hypertension
    • Sheffield, South Yorkshire, United Kingdom
      Sheffield Teaching Hospitals NHS Foundation Trust
    Jun 23, 2022

    Pulmonary Hypertension Trial in United States (Inhaled Iloprost (5 µg), Inhaled Placebo, Sildenafil)

    Terminated
    • Pulmonary Hypertension
    • Inhaled Iloprost (5 μg)
    • +3 more
    • Phoenix, Arizona
    • +33 more
    Mar 26, 2019

    Raynaud Phenomenon Secondary to Systemic Sclerosis Trial in Paris (BOTOX® solution, Placebo group)

    Completed
    • Raynaud Phenomenon Secondary to Systemic Sclerosis
    • BOTOX® solution
    • Placebo group
    • Paris, France
      Hôpital Tenon
    Feb 9, 2022

    Systemic scleRosis and Progressive Digital ulcEr Disease.

    Recruiting
    • Scleroderma
    • +4 more
      • Athens, Greece
        Laikon Hospital of Athens
      Mar 22, 2022

      Lung Cancer Trial in Seoul (iloprost, normal saline)

      Completed
      • Lung Cancer
      • iloprost
      • normal saline
      • Seoul, Korea, Republic of
        Department of Anaesthesiology and Pain Medicine, Anaesthesia and
      Jun 19, 2018

      Fibrotic Pulmonary Sequelae Post-COVID19 Infection Trial in Spain (Pirfenidone, Placebo)

      Recruiting
      • Fibrotic Pulmonary Sequelae Post-COVID19 Infection
      • Hospitalet de Llobregat, Barcelona, Spain
      • +7 more
      Dec 29, 2021

      Raynaud Phenomenon Trial in Grenoble (L-citrulline, Beetroot juice, L-citrulline )

      Recruiting
      • Raynaud Phenomenon
      • L-citrulline
      • +3 more
      • Grenoble, France
        Grenoble University Hospital
      May 12, 2021

      Pulmonary Arterial Hypertension With Inhaled Iloprost Using

      Completed
      • Pulmonary Hypertension
      • Iloprost (Ventavis, BAYQ 6256)
      • Multiple Locations, Portugal
        (unnamed)
      Apr 5, 2018

      Pulmonary Arterial Hypertension Trial in Austria, Germany (lloprost(Ventavis,BAYQ6252, 20 µg/mL), lloprost(Ventavis,BAYQ6252, 10

      Completed
      • Pulmonary Arterial Hypertension
      • lloprost(Ventavis,BAYQ6252, 20 µg/mL)
      • lloprost(Ventavis,BAYQ6252, 10 µg/mL)
      • Graz, Steiermark, Austria
      • +5 more
      Sep 25, 2018

      COMPERA / COMPERA-KIDS

      Recruiting
      • Pulmonary Arterial Hypertension (PAH)
      • Pulmonary Hypertension (PH)
        • Leuven, Belgium
        • +7 more
        Jan 19, 2022

        Pulmonary Arterial Hypertension Trial in Worldwide (PAH Therapies)

        Recruiting
        • Pulmonary Arterial Hypertension
        • PAH Therapies
        • Los Angeles, California
        • +97 more
        Aug 16, 2022

        Scleroderma, Systemic Trial in Grenoble (Iontophoresis of treprostinil, Iontophoresis of )

        Completed
        • Scleroderma, Systemic
        • Iontophoresis of treprostinil
        • Iontophoresis of placebo
        • Grenoble, France
          Grenoble Alps University Hospital
        Apr 8, 2020

        Systemic Sclerosis Trial in Sheffield (Exercise programme)

        Recruiting
        • Systemic Sclerosis
        • Exercise programme
        • Sheffield, United Kingdom
          Sheffield Hallam University
        Jul 19, 2022

        Systemic Sclerosis, Digital Ulcer Trial in Milan (Autologous fat grafting, Sham procedure)

        Unknown status
        • Systemic Sclerosis
        • Digital Ulcer
        • Autologous fat grafting
        • Sham procedure
        • Milan, Italy
          UOC Day Hospital Reumatologia, ASST G. Pini-CTO
        Jan 22, 2018

        Hypertension, Pulmonary Trial in Japan (Iloprost (Ventavis inhaled, BAYQ6256))

        Completed
        • Hypertension, Pulmonary
        • Iloprost (Ventavis inhaled, BAYQ6256)
        • Nagoya, Aichi, Japan
        • +17 more
        Dec 6, 2017

        Efficacy of Ventavis Used in Real-life Setting.

        Completed
        • Pulmonary Arterial Hypertension
        • Inhaled iloprost (Ventavis, BAYQ6256)
        • Many Locations, Poland
          (unnamed)
        Oct 16, 2017

        Raynaud's Phenomenon Isolated Primary, Raynaud's Phenomenon (Secondary), Healthy Trial in Grenoble (Biopsy)

        Completed
        • Raynaud's Phenomenon Isolated Primary
        • +2 more
        • Biopsy
        • Grenoble, Isère, France
          CHU of Grenoble Alpes
        Apr 8, 2020

        Via Insight Program in Class III Pulmonary Arterial Hypertension

        Completed
        • Pulmonary Arterial Hypertension
        • Ventavis (Iloprost, BAYQ6256)
        • Multiple Locations, France
          (unnamed)
        Dec 1, 2017

        Prostacyclin Analogues in Pulmonary Arterial Hypertension

        Completed
        • Pulmonary Hypertension
          • Warsaw, Poland
            Department of Pulmonary Circulation, Thromboembolic Diseases and
          Oct 8, 2020

          Septic Shock Trial in Hillerød (Iloprost+eptifibatide, Placebo)

          Completed
          • Septic Shock
          • Hillerød, Capital Region, Denmark
            Department of Anesthesia and Intensive Care, Nordsjællands Hospi
          Apr 21, 2017